Contact Us
Please Contact Us

toll free: 1800 3070 6727    Email: info@positivebioscience.com

Prolaris is a genomic test helps in predicting prostate cancer aggressiveness in conjunction with clinical parameters such as Gleason score and PSA. Prolaris is the first prognostic test that offers a direct measure of the molecular biology of an individual patient’s prostate cancer. Undergoing the Prolaris test will help a patient determine if they require surgery, chemotherapy or if active monitoring is enough.

  • On my diagnosis of Prostate cancer i was advised Prostatectomy by a doctor. After hearing the side effects of surgery like incontinence i was really stressed and scared. Then i ordered Prolaris which revealed that i have a considerably less aggressive Prostate Cancer and thus I dont need to undergo Prostatectomy. Prolaris reports came as a huge relief for me.

  • I underwent prostatectomy. Post surgery my doctor wasnot sure whether i need adjuvant radation therapy or not as it depends on how likely the cancer will come back. My doctor prescribed me Prolaris which revealed that chances of biochemical recurrence in me is very low. I could avoid unwarranted adjuvant therapy and treatment cost only because of Prolaris.

REPORTS: A SIMPLE GUIDE TO UNDERSTANDING

Reportsprovide information that allows physicians to:

  • Better understand a patients’ risk for specific health conditions

  • Prescribe more suitable medications at optimal dosages for patients, as needed.

  • Suggest early lifestyle and diet interventions to help control or prevent certain health conditions.

People also bought this

  • health_plus

    31% more accurate in identifying cancer driver mutations

    Better treatment recommendation

    Complementary consultation with your doctor

    INR 93925
    INR 110500

  • protect-25

    Best treatment recommendation

    Provides information on pathway analysis

    Includes Positive Bioscience expert comments and complementary consultation with your doctor

    INR 165750
    INR 195000

  • PositiveProtectOnco

    Industry leading 51 gene tes

    Learn your risk for 11 cancers

    Know risk to secondary cancers in cancer patients

    INR 254150
    INR 299000

Copyright ©2017 Positive Bioscience, Inc. All Rights Reserved